Tools

U.S. regulators have approved Novartis AG’s Ilaris to treat children and adults with a rare but potentially fatal auto-inflammatory disease,… »   

An analysis by U.S. regulators found Bristol-Myers Squibb and Elan Corp’s antibiotic Maxipime was not associated with a higher rate… »   

Consumers of over-the-counter homeopathic and “natural” cold remedies should carefully research such treatment options and properly follow dosage instructions, urges… »   

The effectiveness of Vyvanse for treating attention deficit-hyperactivity disorder (ADHD) in school-aged children is maintained for a good 13… »   

Savient Pharmaceuticals Inc’s experimental gout drug is safe and effective for certain patients with the debilitating joint disorder and should… »   

U.S. regulators warned Matrixx Initiatives to stop selling intranasal versions of its zinc-containing Zicam cold remedy, following more than 130… »   

A cream version of an intravenous drug used to treat colon cancers and other tumors can be used to fight… »   

Canada’s Health Ministry on Monday approved a new source of Technetium-99m (Tc-99m) medical isotopes.

Boston-based Lantheus Medical Imaging has been… »   

A study that found possible heart risks with attention deficit drugs had limitations and should not prompt parents to stop… »   

Merck & Co Inc’s top-selling drug Singulair and similar medicines should come with a caution about reports of psychiatric… »